BEAM

Stock ticker: NASDAQ

PRICE

CHANGE

CAPITALIZATION

Beam Therapeutics (BEAM) Earnings Date & Reports

Get AI intraday signals

A.I. Advisor

published Earnings

BEAM is expected to report earnings to rise 8.55% to -126 cents per share on March 04

Beam Therapeutics BEAM Stock Earnings Reports

Q4'24

Est.

$-1.27

Q3'24

Beat

by $0.01

Q2'24

Beat

by $0.02

Q1'24

Beat

by $0.20

Q4'23

Beat

by $2.42

The last earnings report on November 05 showed earnings per share of -116 cents, beating the estimate of -117 cents. With 1.54M shares outstanding, the current market capitalization sits at 2.37B.

View a ticker or compare two or three

Compare

BEAM

Setup

Buy or SellView

Daily Signalchanged days ago

Gain/Loss if bought

View Trends For BEAM
(Try 14 days for Free)

Ad is loading...

A.I.Advisor

published price charts

View to see Real Time Patterns for BEAM (Try 14 days for Free)

A.I. Advisor

published General Information

General Information

a company, which develops and commercializes DNA base editing technologies for the treatment of human disease.

Industry Biotechnology

Profile

Fundamentals

Details

Industry

N/A

Address

238 Main Street

Phone

+1 857 327-8775

Employees

436

Web

https://www.beamtx.com